Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Medicinal Chemistry|August 10, 2013
Phenotypic screening as a strategic component of drug discovery programs targeting novel antiparasitic and antimycobacterial agents: an editorialJohn A ButeraCurrent Topics in Medicinal Chemistry|October 5, 2006
Ligands targeting the excitatory amino acid transporters (EAATs)John Dunlop, John A ButeraBioorganic & Medicinal Chemistry Letters|May 3, 2005
Synthesis and bladder smooth muscle relaxing properties of substituted 3-amino-4-aryl-(and aralkyl-)cyclobut-3-ene-1,2-dionesJohn A Butera, Douglas J Jenkins, Joseph R Lennox, et al.Bioorganic & Medicinal Chemistry Letters|March 6, 2010
Identification of pyridazino[4,5-b]indolizines as selective PDE4B inhibitorsAndrew F Donnell, Paul J Dollings, John A Butera, et al.Biochemical Pharmacology|November 18, 2008
Novel progesterone receptor modulators with gene selective and context-dependent partial agonismThomas J Berrodin, Scott A Jelinsky, Nilsa Graciani, et al.Bioorganic & Medicinal Chemistry Letters|July 21, 2009
Discovery of a class of potent gap-junction modifiers as novel antiarrhythmic agentsEugene L Piatnitski Chekler, John A Butera, Li Di, et al.Journal of Medicinal Chemistry|January 23, 2004
Design, synthesis, and biological evaluation of thio-containing compounds with serum HDL-cholesterol-elevating propertiesHassan Elokdah, Theodore S Sulkowski, Magid Abou-Gharbia, et al.Assay and Drug Development Technologies|May 18, 2010
Ion channel screening plates: design, construction, and maintenanceScott C Mayer, John A Butera, David J Diller, et al.European Journal of Pharmacology|January 27, 2009
Pharmacological comparison of muscarinic ligands: historical versus more recent muscarinic M1-preferring receptor agonistsJulia N Heinrich, John A Butera, Tikva Carrick, et al.Journal of Medicinal Chemistry|January 30, 2009
Discovery of (2S,4R)-1-(2-aminoacetyl)-4-benzamidopyrrolidine-2-carboxylic acid hydrochloride (GAP-134)13, an orally active small molecule gap-junction modifier for the treatment of atrial fibrillationJohn A Butera, Bjarne Due Larsen, James K Hennan, et al.Pageof 2